What is Kernel?
Kernel is a pioneering entity at the intersection of neuroscience and digital health, dedicated to advancing brain health through accessible, evidence-based measurement technologies. The company specializes in non-invasive brain scans that utilize advanced algorithms to provide granular insights into cognitive function. By offering tools such as Brain Age and specialized cognitive trackers, Kernel enables both wellness-focused consumers and clinical professionals to monitor brain health with unprecedented precision. Their technology is specifically designed to integrate into clinical workflows, providing healthcare providers with actionable data to improve patient outcomes, particularly in the management of complex conditions such as depression. Through its dual focus on research and commercial application, Kernel is establishing a new standard for how brain function is quantified and understood in real-world settings.
How much funding has Kernel raised?
Kernel has raised a total of $53M across 1 funding round:
Series C
$53M
Series C (2020): $53M with participation from Manta Ray Ventures, Tiny Blue Dot, General Catalyst, Khosla Ventures, Eldridge, and Bryan Johnson
Key Investors in Kernel
General Catalyst
General Catalyst is a prominent venture capital firm that partners with founders to build enduring, transformational enterprises across diverse sectors including healthcare and technology.
Khosla Ventures
Khosla Ventures provides strategic advice and capital to entrepreneurs developing breakthrough technologies, with a strong emphasis on health, AI, and enterprise innovation.
Manta Ray Ventures
Manta Ray Ventures is an investment firm focused on supporting high-growth companies that leverage technology to solve complex global challenges.
What's next for Kernel?
With the successful closure of this major strategic investment, Kernel is poised to enter a phase of rapid operational scaling and market penetration. The company's roadmap likely involves the expansion of its clinical footprint, enabling more healthcare providers to adopt Kernel Scans as a standard diagnostic component. Furthermore, the firm is expected to deepen its research initiatives, potentially unlocking new therapeutic pathways for neurological and psychiatric conditions. As Kernel continues to refine its hardware and software ecosystem, the focus will shift toward establishing long-term partnerships with medical institutions and health systems. This strategic growth phase will be critical in validating the efficacy of their technology at scale, ultimately aiming to transform brain health from a reactive field into a proactive, data-driven discipline.
See full Kernel company page
